Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Wesolowski

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Proceedings of the National Academy of Sciences of the United States of America|January 6, 1999
Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitroJ E Fisher, M J Rogers, J M Halasy, et al.
Open Forum Infectious Diseases|January 23, 2016
Acute Infections, Cost per Infection and Turnaround Time in Three United States Hospital Laboratories Using Fourth-Generation Antigen-Antibody Human Immunodeficiency Virus ImmunoassaysLaura G Wesolowski, Muazzam Nasrullah, Robert W Coombs, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|March 14, 2015
Nucleic acid testing by public health referral laboratories for public health laboratories using the U.S. HIV diagnostic testing algorithmLaura G Wesolowski, Kelly Wroblewski, Spencer B Bennett, et al.
AIDS and Behavior|November 1, 2022
Distribution of HIV Self-tests by Men Who have Sex with Men (MSM) to Social Network AssociatesShilpa N Patel, Pollyanna R Chavez, Craig B Borkowf, et al.
Sexually Transmitted Diseases|April 29, 2020
Routine HIV Test Results in 6 US Clinical Laboratories Using the Recommended Laboratory HIV Testing Algorithm With Geenius HIV 1/2 Supplemental AssayLaura G Wesolowski, Pollyanna R Chavez, Ana María Cárdenas, et al.
MMWR. Morbidity and Mortality Weekly Report|January 24, 2020
Trends in HIV-2 Diagnoses and Use of the HIV-1/HIV-2 Differentiation Test - United States, 2010-2017Anne H Peruski, Laura G Wesolowski, Kevin P Delaney, et al.
JMIR Research Protocols|February 4, 2020
Prospective Evaluation of HIV Testing Technologies in a Clinical Setting: Protocol for Project DETECTJoanne D Stekler, Lauren R Violette, Hollie A Clark, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 29, 2020
Performance evaluation of four point-of-care HIV tests using unprocessed specimensPollyanna R Chavez, Heather M Bradley, Laura G Wesolowski, et al.
Journal of Medicinal Chemistry|October 6, 2000
Nonpeptide alpha(v)beta(3) antagonists. 1. Transformation of a potent, integrin-selective alpha(IIb)beta(3) antagonist into a potent alpha(v)beta(3) antagonistM E Duggan, L T Duong, J E Fisher, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Proceedings of the National Academy of Sciences of the United States of America|January 6, 1999
Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitroJ E Fisher, M J Rogers, J M Halasy, et al.
Open Forum Infectious Diseases|January 23, 2016
Acute Infections, Cost per Infection and Turnaround Time in Three United States Hospital Laboratories Using Fourth-Generation Antigen-Antibody Human Immunodeficiency Virus ImmunoassaysLaura G Wesolowski, Muazzam Nasrullah, Robert W Coombs, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|March 14, 2015
Nucleic acid testing by public health referral laboratories for public health laboratories using the U.S. HIV diagnostic testing algorithmLaura G Wesolowski, Kelly Wroblewski, Spencer B Bennett, et al.
AIDS and Behavior|November 1, 2022
Distribution of HIV Self-tests by Men Who have Sex with Men (MSM) to Social Network AssociatesShilpa N Patel, Pollyanna R Chavez, Craig B Borkowf, et al.
Sexually Transmitted Diseases|April 29, 2020
Routine HIV Test Results in 6 US Clinical Laboratories Using the Recommended Laboratory HIV Testing Algorithm With Geenius HIV 1/2 Supplemental AssayLaura G Wesolowski, Pollyanna R Chavez, Ana María Cárdenas, et al.
MMWR. Morbidity and Mortality Weekly Report|January 24, 2020
Trends in HIV-2 Diagnoses and Use of the HIV-1/HIV-2 Differentiation Test - United States, 2010-2017Anne H Peruski, Laura G Wesolowski, Kevin P Delaney, et al.
JMIR Research Protocols|February 4, 2020
Prospective Evaluation of HIV Testing Technologies in a Clinical Setting: Protocol for Project DETECTJoanne D Stekler, Lauren R Violette, Hollie A Clark, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 29, 2020
Performance evaluation of four point-of-care HIV tests using unprocessed specimensPollyanna R Chavez, Heather M Bradley, Laura G Wesolowski, et al.
Journal of Medicinal Chemistry|October 6, 2000
Nonpeptide alpha(v)beta(3) antagonists. 1. Transformation of a potent, integrin-selective alpha(IIb)beta(3) antagonist into a potent alpha(v)beta(3) antagonistM E Duggan, L T Duong, J E Fisher, et al.
Pageof 5